{"status": "Ok", "redirect_url": "https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2026/Teva-to-AcquireEmalexBiosciences-Adding-NDA-Ready-First-in-Class-Therapy-to-Neuroscience-Pipeline-and-Accelerating-Tevas-Pivot-to-Growth-Strategy/default.aspx", "message": "News view counter 688093 successfully enlarged"}